Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
SE1-H5226 | Human | Human Serpin A1 Protein, His Tag |
|
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Alfalastin (LFB SA) | Approved | Lfb Biotechnologies Sas | Alfalastin | France | alpha 1-Antitrypsin Deficiency | Lfb Biotechnologies Sas | 2005-08-01 | alpha 1-Antitrypsin Deficiency | Details | |
Alfalastin (LFB SA) | Approved | Lfb Biotechnologies Sas | Alfalastin | France | alpha 1-Antitrypsin Deficiency | Lfb Biotechnologies Sas | 2005-08-01 | alpha 1-Antitrypsin Deficiency | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Fazirsiran | TAK-999; ADS-001; ARO-AAT | Phase 3 Clinical | Arrowhead Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd | alpha 1-Antitrypsin Deficiency; Hepatic Insufficiency | Details |
Belcesiran | DCR-A1AT | Phase 2 Clinical | Dicerna Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc | alpha 1-Antitrypsin Deficiency | Details |
INBRX-101 | AAT-IgG-Fc; AAT-Fc; rhAAT-Fc; AT-292; INBRX-101 | Phase 2 Clinical | Inhibrx | alpha 1-Antitrypsin Deficiency; Emphysema | Details |
VX-864 | VX-864 | Phase 2 Clinical | Vertex Pharmaceuticals Incorporated | alpha 1-Antitrypsin Deficiency | Details |
KB-408 | KB-408 | Phase 1 Clinical | Krystal Biotech Inc | alpha 1-Antitrypsin Deficiency | Details |
VX-668 | VX-668; VX668 | Phase 1 Clinical | Vertex Pharmaceuticals Incorporated | alpha 1-Antitrypsin Deficiency | Details |
WVE-006 | WVE-006 | Phase 1 Clinical | Wave Life Sciences Ltd | alpha 1-Antitrypsin Deficiency | Details |
VX-634 | VX-634 | Phase 1 Clinical | Vertex Pharmaceuticals Incorporated | alpha 1-Antitrypsin Deficiency | Details |
Alpha-1 antitrypsin (Kalytera Therapeutics) | Clinical | Clalit Health Services | Details | ||
Fazirsiran | TAK-999; ADS-001; ARO-AAT | Phase 3 Clinical | Arrowhead Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd | alpha 1-Antitrypsin Deficiency; Hepatic Insufficiency | Details |
Belcesiran | DCR-A1AT | Phase 2 Clinical | Dicerna Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc | alpha 1-Antitrypsin Deficiency | Details |
INBRX-101 | AAT-IgG-Fc; AAT-Fc; rhAAT-Fc; AT-292; INBRX-101 | Phase 2 Clinical | Inhibrx | alpha 1-Antitrypsin Deficiency; Emphysema | Details |
VX-864 | VX-864 | Phase 2 Clinical | Vertex Pharmaceuticals Incorporated | alpha 1-Antitrypsin Deficiency | Details |
KB-408 | KB-408 | Phase 1 Clinical | Krystal Biotech Inc | alpha 1-Antitrypsin Deficiency | Details |
VX-668 | VX-668; VX668 | Phase 1 Clinical | Vertex Pharmaceuticals Incorporated | alpha 1-Antitrypsin Deficiency | Details |
WVE-006 | WVE-006 | Phase 1 Clinical | Wave Life Sciences Ltd | alpha 1-Antitrypsin Deficiency | Details |
VX-634 | VX-634 | Phase 1 Clinical | Vertex Pharmaceuticals Incorporated | alpha 1-Antitrypsin Deficiency | Details |
Alpha-1 antitrypsin (Kalytera Therapeutics) | Clinical | Clalit Health Services | Details |
This web search service is supported by Google Inc.